OWC Pharmaceutical Research Corp. Share Price Other OTC
Equities
OWCP
US67109N1081
Advanced Medical Equipment & Technology
Sales 2017 | - | Sales 2018 | - | Capitalization | 1.54Cr 128.24Cr |
---|---|---|---|---|---|
Net income 2017 | -40L -33Cr | Net income 2018 | -1Cr -83Cr | EV / Sales 2017 | - |
Net cash position 2017 | 10L 8.1Cr | Net cash position 2018 | 34.64L 29Cr | EV / Sales 2018 | - |
P/E ratio 2017 |
-14.5
x | P/E ratio 2018 |
-1.21
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 21/20/21 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 16/14/16 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 02/16/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 25/20/25 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 21/20/21 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
1st Jan change | Capi. | |
---|---|---|
-12.36% | 1.92TCr | |
-40.05% | 295.88Cr | |
+23.79% | 196.26Cr | |
+1.29% | 169.05Cr | |
+28.87% | 126.82Cr | |
-14.61% | 98Cr | |
-20.31% | 91Cr | |
+3.53% | 80Cr | |
-24.78% | 63Cr |